Ketamine/esketamine treatment for resistant depression in children and adolescents: a PRISMA systematic review.

Ketamine and esketamine have been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior in adults. The current paper aimed to systematically review the available data on their ef…

Preview only. Read the full abstract at the source